Oncotarget

Reviews:

Microenvironmental regulation of the progression of oral potentially malignant disorders towards malignancy

Ruixue Ai, Yan Tao, Yilong Hao, Lu Jiang, Hongxia Dan, Ning Ji, Xin Zeng, Yu Zhou _ and Qianming Chen

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:81617-81635. https://doi.org/10.18632/oncotarget.20312

Metrics: PDF 1343 views  |   HTML 1913 views  |   ?  


Abstract

Ruixue Ai1, Yan Tao1, Yilong Hao1, Lu Jiang1, Hongxia Dan1, Ning Ji1, Xin Zeng1, Yu Zhou1 and Qianming Chen1

1State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Department of Oral Medicine of West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China

Correspondence to:

Yu Zhou, email: zhouyu19830306@sina.com

Qianming Chen, email: qmchen@scu.edu.cn

Keywords: immunity, premalignant condition, microenvironment, oral potentially malignant disorder, therapeutics

Received: May 24, 2017     Accepted: August 04, 2017     Published: August 17, 2017

ABSTRACT

Oral potentially malignant disorders (OPMD) develop in a complex tissue microenvironment where they grow sustainably, acquiring oral squamous cell carcinoma (OSCC) characteristics. The malignant tumor depends on interactions with the surrounding microenvironment to achieve loco-regional invasion and distant metastases. Unlike abnormal cells, the multiple cell types in the tissue microenvironment are relatively stable at the genomic level and, thus, become therapeutic targets with lower risk of resistance, decreasing the risk of OPMD acquiring cancer characteristics and carcinoma recurrence. However, deciding how to disrupt the OPMD and OSCC microenvironments is itself a daunting challenge, since their microenvironments present opposite capacities, resulting in diverse consequences. Furthermore, recent studies revealed that tumor-associated immune cells also participate in the process of differentiation from OPMD to OSCC, suggesting that reeducating stromal cells may be a new strategy to prevent OPMD from acquiring OSCC characteristics and to treat OSCC. In this review, we discuss the characteristics of the microenvironment of OPMD and OSCC as well as new therapeutic strategies.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 20312